Accessibility Menu
Humana logo

Humana(NYSE) HUM

Market Cap$46.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1969)+189,071%
5 Year-5%
1 Year+70%
1 Month+1%
$363.28
-6.54%
-25.43Today
Humana last closing stock price
MetricPriceDate
Last closeUSD 388.712026-07-28
Humana stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.87%USD 404.342026-07-21
1 month+1.27%USD 383.842026-06-26
3 month+60.26%USD 242.552026-04-29
Year to date+52.89%USD 254.242025-12-31
1 year+70.32%USD 228.232025-07-28
3 year-11.08%USD 437.142023-07-28
5 year-5.13%USD 409.742021-07-29
Since inception+189,071.4%USD 0.211969-07-02

Humana Financials at a Glance

Market Cap

$46.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$145.68B

Net Income (TTM)

$1.28B

EPS (TTM)

$9.34

P/E Ratio

41.60

Dividend

$3.54

Beta (Volatility)

0.42 (Low)

Price

$363.28

Volume

1,837,691.386

Open

$388.20

Previous Close

$388.71

Daily Range

$356.50 - $395.30

52-Week Range

$163.11 - $428.88

Estimated Earnings Date

Nov 4, 2026

HUM: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Humana

Humana helps people pay for doctors, hospitals, and medicine through various insurance plans. It also runs clinics and pharmacies to provide health care directly to its members. The company mainly serves seniors and people with lower incomes across the United States.

What Humana Offers

  • Individual Medicare Advantage: Health insurance for seniors that replaces standard government benefits; represents 70.3% of consolidated premiums and services revenue.
  • State-based Contracts: Medicaid and long-term care services provided through deals with state governments; accounts for 11.2% of consolidated premiums and services revenue.
  • Group Medicare Advantage: Employer-sponsored health plans for retired workers; makes up 7.0% of consolidated premiums and services revenue.
  • Pharmacy Solutions: Mail-order and specialty drug services that deliver medicine to patients at home or in clinics.
  • Primary Care: Value-based medical centers operating under the CenterWell and Conviva brands for senior patients.

Recent Strategic Moves

  • Sold a 60% stake in Gentiva Hospice on August 11, 2022, while keeping a 35% minority interest.
  • Began a partnership with Welsh, Carson, Anderson & Stowe to build and run primary care centers for seniors.
  • Started the new T-5 TRICARE contract on January 1, 2025, to provide administrative health services for military personnel in 24 states.
  • Expanded the CenterWell brand to include home health and pharmacy services to create a unified care experience.

Why the Company Stands Out

Humana uses an integrated care model that combines insurance coverage with its own pharmacies and doctor offices. This approach uses data analytics to track member health and help providers move from per-visit fees to quality-based payments.

Humana by the Numbers

  • Total revenue reached $32.5 billion in Q4 2025, up 11.3% from $29.2 billion in Q4 2024.
  • Net income fell to a loss of $796 million in Q4 2025, down 14.9% from a loss of $693 million in Q4 2024.
  • Free cash flow dropped to negative $1.9 billion in Q4 2025, down 171.8% from negative $682 million in Q4 2024.
  • The Individual Medicare Advantage segment generated $90.4 billion in premiums and services revenue during 2025.
  • Medical benefit plan membership included approximately 15 million members as of December 31, 2025.

The Bottom Line

Humana has shifted from a traditional insurance company into a broader healthcare provider by growing its own clinical and pharmacy services. While revenue continues to grow, the company is navigating rising medical costs and changes in government quality ratings.

AI Generated • Apr 19, 2026

Industry

Healthcare Providers and Services

Employees

67,060

CEO

James A. Rechtin, MBA

Headquarters

Louisville, KY 40202, US

HUM Financials

Key Financial Metrics (TTM)

Gross Margin

5.80%

Operating Margin

1.51%

Net Income Margin

0.88%

Return on Equity

6.92%

Return on Capital

4.75%

Return on Assets

2.24%

Earnings Yield

2.40%

Dividend Yield

0.91%

Payout Ratio

33.62%

Stock Overview

Market Cap

$46.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

120.06M

Volume

1.84M

Avg. Volume

1.55M

Financials (TTM)

Gross Profit

$8.45B

Operating Income

$2.20B

EBITDA

$3.02B

Operating Cash Flow

$2.54B

Capital Expenditure

-$590.00M

Free Cash Flow

$1.95B

Cash & ST Invst.

$23.87B

Total Debt

$14.25B

Humana Performance Analysis

Humana annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 92,922,000,00011.1%
20232023-12-31USD 106,440,000,00014.5%
20242024-12-31USD 117,811,000,00010.7%
20252025-12-31USD 129,711,000,00010.1%
Humana sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.8%
Q42025-12-31-0.4%
Q12026-03-3121.9%
Q22026-06-303.1%
Humana annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 22.08-2.6%
20232023-12-31USD 20.00-9.4%
20242024-12-31USD 9.99-50.1%
20252025-12-31USD 9.83-1.5%
Humana sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-64.1%
Q42025-12-31-508.0%
Q12026-03-31248.7%
Q22026-06-30-41.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$40.87B

+26.2%

Gross Profit

-$5.94B

-223.2%

Gross Margin

-14.54%

N/A

Market Cap

$46.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$695.93K

N/A

Employees

67,060

N/A

Net Income

$694.00M

+27.3%

EBITDA

$1.26B

+15.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$23.87B

+490.9%

Total Debt

$14.25B

+13.2%

Accounts Receivable

$5.70B

+26.4%

Inventory

$0.00

N/A

Long Term Debt

$11.98B

-4.8%

Short Term Debt

$2.27B

N/A

Return on Assets

2.24%

N/A

Return on Invested Capital

6.43%

N/A

Free Cash Flow

$1.83B

+58.5%

Operating Cash Flow

$1.97B

+54.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLNHaleon plc
$10.24-0.24%
IQVIQVIA Holdings Inc.
$245.66+1.12%
AAgilent Technologies, Inc.
$139.63-0.65%
ONCBeOne Medicines AG
$326.58-1.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.10-0.10%
FFord Motor Company
$15.49+0.04%
INTCIntel
$81.97-0.05%
NVDANvidia
$191.03-0.03%

Questions About HUM

What is the current price of Humana?

Humana is trading at $363.48 per share.

What is the 52-week range for Humana?

Over the past 52 weeks, Humana has traded between $163.11 and $428.88.

How much debt does Humana have?

As of the most recent reporting period, Humana reported total debt of $13.99B.

How much cash does Humana have on hand?

Humana reported $4.95B in cash and cash equivalents in its most recent financial results.

What is Humana’s dividend yield?

Humana currently has a dividend yield of 0.91%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.